Back to search

Article

Viral evolution of T1L mammalian orthoreovirus enhances breast cancer stem-like cell killing

2025-12-11

Abstract excerpt

<h4>Background</h4> Breast cancer is the second leading cause of death in women in the US. Among the different subtypes of breast cancer, estrogen receptor positive (ER+) has a more favorable prognosis; however, patients can experience cancer recurrence 10 years or more after initial diagnosis. Breast cancer stem-like cells (BCSCs) are slowly proliferating cells that drive metastasis and resistance to therapies t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d0577850-5de8-5645-aa5d-8177694a9a23
DOI
10.64898/2025.12.10.693591
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Viral evolution of T1L mammalian orthoreovirus enhances breast cancer stem-like cell killingDOI 10.64898/2025.12.10.693591
Non-canonical cell death by reassortant reovirusSemantic proximity
Identification of oncolytic vaccinia restriction factors in canine high-grade mammary tumor cells using single-cell transcriptomicsSemantic proximity
Chemotherapy reshapes cellular clonal landscape via persister programs in breast cancer xenograftsSemantic proximity
Oncolytic virotherapy: the questions and the promiseSemantic proximity
Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus DevelopmentSemantic proximity
Enhanced Killing of Triple-Negative Breast Cancer Cells by Reassortant Reovirus and Topoisomerase InhibitorsSemantic proximity
OvirusTdb: A database of oncolytic viruses for the advancement of therapeutics in cancerSemantic proximity
Evolution of Oncolytic Viruses: Novel Strategies for Cancer TreatmentSemantic proximity
Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and MechanismsSemantic proximity
Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeuticsSemantic proximity
Oncolytic viral therapies – the clinical experienceSemantic proximity
A ‘one-two punch’ therapy strategy to target chemoresistance in estrogen receptor positive breast cancerSemantic proximity
Select a neighboring publication to make it the new centre.